Skip to content
Bioxytran, Inc. logo

Bioxytran, Inc. Alternatives & Competitors

12 companies similar to Bioxytran, Inc. — Bioxytran is a company focused on developing treatments for stroke and Ischemia.

Companies similar to Bioxytran, Inc.

VG Life Sciences logo — alternative to Bioxytran, Inc.

VG Life Sciences

Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...

Fabre-Kramer Pharmaceuticals, Inc. logo — alternative to Bioxytran, Inc.

Fabre-Kramer Pharmaceuticals, Inc.

The company was formed to identify, develop and commercialize psychotropic drugs with sign...

Topica Pharmaceuticals logo — alternative to Bioxytran, Inc.

Topica Pharmaceuticals

Developing the first highly effective and safe topical therapy for onychomycosis.

Idenix Pharmaceuticals logo — alternative to Bioxytran, Inc.

Idenix Pharmaceuticals

Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, wi...

Rival Readout

Competing with Bioxytran, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
HEART METABOLICS LTD logo — alternative to Bioxytran, Inc.
Tolerx, Inc. logo — alternative to Bioxytran, Inc.
Acesion Pharma logo — alternative to Bioxytran, Inc.

Acesion Pharma

Danish biotech developing novel treatments for Atrial Fibrillation

Alavita logo — alternative to Bioxytran, Inc.

Alavita

Votre épicerie bio, locale et durable au Luxembourg.

ABM Therapeutics logo — alternative to Bioxytran, Inc.

ABM Therapeutics

An innovative drug discovery company focusing on targeted therapy for brain cancers as wel...

Stemedica Cell Technologies, Inc logo — alternative to Bioxytran, Inc.

Stemedica Cell Technologies, Inc

Developing Breakthrough Progenitor Cell and Protein Therapeutics

Sen-Jam Pharmaceutical logo — alternative to Bioxytran, Inc.

Sen-Jam Pharmaceutical

We’re changing the way the world treats inflammation and the way the pharma industry treat...

Halo Therapeutics logo — alternative to Bioxytran, Inc.

Halo Therapeutics

The DeepTech Health Company

About Bioxytran, Inc.

Bioxytran, Inc. is a biotechnology company focusing on revolutionizing stroke and Ischemia treatments. Since its founding in 2008, the company has been dedicated to developing novel drugs under FDA regulation, specifically targeting hypoxia brain and heart ischemia, as well as viral infections such as coronavirus and i...

Business keywords

Bioxytran, Stroke Treatment, Ischemia, Drug Development, FDA Regulation, Hypoxia, Brain Ischemia, Heart Ischemia, Viral Infection, Coronavirus, Influenza, Pharmaceuticals, Medical Research, Clinical Trials

Frequently Asked Questions

Companies similar to Bioxytran, Inc. include VG Life Sciences, Fabre-Kramer Pharmaceuticals, Inc., Topica Pharmaceuticals, Idenix Pharmaceuticals, HEART METABOLICS LTD. They work in Biotechnology and Health Care and share Bioxytran, Inc.'s focus on clinical trials, pharmaceuticals and drug development.
Bounce Watch lists 12 companies that share Bioxytran, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.
Bioxytran, Inc. is a biotechnology company focusing on revolutionizing stroke and Ischemia treatments. Since its founding in 2008, the company has been dedicated to developing novel drugs under FDA regulation, specifically targeting hypoxia brain and heart ischemia, as well as viral infections such as coronavirus and i...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Bioxytran, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Bioxytran, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Feb 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout